van Lierop Anton C, Basson Ola, Fagan Johannes J
Division of Otolaryngology, University of Cape Town.
S Afr J Surg. 2008 Feb;46(1):22-5.
Total glossectomy (with or without total laryngectomy) followed by postoperative radiotherapy remains the principal treatment method for advanced base of tongue carcinoma. The procedure remains controversial owing to poor cure rates and the inevitable functional deficits associated with it. However, even though total glossectomy is a major surgical procedure that impacts on speech, deglutition and quality of life, it may offer patients the best chance of cure in many centres, especially in the developing world.
We did a retrospective chart review of all patients at Groote Schuur Hospital, Cape Town, who had undergone total glossectomy, with or without total laryngectomy, for stage IV squamous cell carcinoma (SCC) of the tongue between 1998 and 2004.
Eight patients had a total glossectomy performed during the study period. At 2, 3 and 5 years 63%, 38% and 25% of patients respectively were alive without disease. No patient required permanent nasogastric or gastrostomy feeding, and all returned to a full oral diet. Three of 5 patients who had laryngeal preservation and could be assessed for speech had intelligible speech. All but 1 patient (88%) reported pain relief following surgical excision. Perineural invasion was present in 75%, and 38% had positive resection margins. Five patients had recurrence, 2 cervical, 1 local, and 2 local and cervical.
Advanced SCC of the tongue is a devastating disease causing severe pain and disorders of speech and swallowing. Total glossectomy (with or without total laryngectomy) and postoperative radiotherapy is a reasonable treatment option, particularly in the developing world setting. It has cure rates superior to primary radiotherapy, and provides motivated patients with excellent pain relief and a reasonable quality of life.
全舌切除术(伴或不伴全喉切除术)联合术后放疗仍是晚期舌根癌的主要治疗方法。由于治愈率低以及与之相关的不可避免的功能缺陷,该手术仍存在争议。然而,尽管全舌切除术是一种影响言语、吞咽和生活质量的大型外科手术,但在许多中心,尤其是在发展中国家,它可能为患者提供最佳的治愈机会。
我们对开普敦格罗特·舒尔医院1998年至2004年间因IV期舌鳞状细胞癌接受全舌切除术(伴或不伴全喉切除术)的所有患者进行了回顾性病历审查。
在研究期间,有8例患者接受了全舌切除术。在2年、3年和5年时,分别有63%、38%和25%的患者无病存活。没有患者需要长期鼻饲或胃造口喂养,所有患者都恢复了正常经口饮食。5例保留喉且可评估言语的患者中有3例言语清晰。除1例患者外,所有患者(88%)报告手术切除后疼痛缓解。75%的患者存在神经周围侵犯,38%的患者切缘阳性。5例患者复发,2例为颈部复发,1例为局部复发,2例为局部和颈部复发。
晚期舌鳞状细胞癌是一种毁灭性疾病,会导致严重疼痛以及言语和吞咽障碍。全舌切除术(伴或不伴全喉切除术)及术后放疗是一种合理的治疗选择,尤其是在发展中国家的情况下。其治愈率优于单纯放疗,并能为有积极性的患者提供良好的疼痛缓解和合理的生活质量。